川控股(01420.HK)2021年扭虧為盈至150萬新加坡元
格隆匯3月31日丨川控股(01420.HK)公吿,截至2021年12月31日止年度,集團的總收益約為8540萬新加坡元,同比增加約18.0%。毛利率約為5.1%(2020年12月31日:毛損率約5.6%)。受惠於收益增加以及新加坡政府的財務援助有助減輕集團的財務負擔,集團呈報業務轉虧為盈,年度溢利約為150萬新加坡元(2020年12月31日:年內虧損約為840萬新加坡元)。每股基本盈利為0.14新加坡仙。
總收益增加乃主要歸因於報吿年度內新加坡政府進一步放寬COVID-19的疫情限制後,業務營運逐步恢復,以及更多項目竣工後確認收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.